Story thread · 17 reports / 3 sources

Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay

finance.yahoo.com · 3d

Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay

How the coverage leans

Across 3 sources · syndicated copies counted once

First report: TSMC, IBD Stock Of The Day, Rises Above Early Buy Point As Chip Stocks Rally investors.com, 6d

The coverage

  1. Family History May Up CRC Risk in IBD, in General Population

    medscape.com · 3d

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.